Lefebvre Eric has filed 8 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 45650 shares of PLIANT THERAPEUTICS, INC. ($PLRX) on January 23, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | A | Common Stock | 45650 | $0.00 | 240,224.0000 | 0 | 23.46% | 0.00% |
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | A | Stock Option (Right to Buy) | 91300 | $0.00 | 91,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | S | Common Stock | 18478 | $11.20 | 194,574.0000 | 0 | 8.67% | 0.00% |
| July 10, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | S | Common Stock | 12319 | $11.56 | 213,052.0000 | 0 | 5.47% | 0.00% |
| July 9, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | A | Common Stock | 24063 | $0.00 | 225,371.0000 | 0 | 11.95% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | A | Common Stock | 42900 | $0.00 | 199,820.0000 | 0 | 27.34% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | A | Stock Option (Right to Buy) | 85800 | $0.00 | 85,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Lefebvre Eric | Chief Medical Officer | S | Common Stock | 10295 | $17.23 | 156,920.0000 | 0 | 6.16% | 0.00% |